TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26147744

Group type: EXPERIMENTAL
Intervention: Probability-modifying plot (PMP)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Natural frequency tree (NFT)
Number of subjects: 874

Group type: COMPARATOR
Intervention: Fagan's nomogram
Number of subjects: 874

Group type: COMPARATOR
Intervention: Text summary of sensitivity and specificity
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: PMP and NFT arms
Number of subjects: 874
Study: 23391845

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention program including education on medication adherence and hypertension, and provision of a home blood pressure monitoring device.
Number of subjects: 176

Group type: COMPARATOR
Intervention: Usual pharmacy care (control group).
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention program (compared to control).
Number of subjects: 176
Study: 20559696

Group type: EXPERIMENTAL
Intervention: Hepatitis B education (experimental group)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Physical activity education (control group)
Number of subjects: 218
Study: 18483061

Group type: EXPERIMENTAL
Intervention: Fruit tuck shops in intervention schools
Number of subjects: 1976

Group type: EXPERIMENTAL
Intervention: Fruit tuck shops with school food policy restrictions
Number of subjects: 1976

Group type: COMPARATOR
Intervention: No food allowed
Number of subjects: 1976

Group type: COMPARATOR
Intervention: No restrictions on food
Number of subjects: 1976
Study: 16475056

Group type: EXPERIMENTAL
Intervention: Interval-trained athletes
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 101
Study: 15071244

Group type: EXPERIMENTAL
Intervention: DDDR pacing
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: VDD pacing
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: VVIR pacing
Number of subjects: 67
Study: 10611207

Group type: EXPERIMENTAL
Intervention: HCG priming (10,000 IU) before immature oocyte retrieval
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non-HCG primed group
Number of subjects: 17
Study: 9166129

Group type: EXPERIMENTAL
Intervention: 5 mg/kg oral DMSA
Number of subjects: 57
Study: 1540053

Group type: EXPERIMENTAL
Intervention: Transfer factor (1 mL at 3-month intervals after operation)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 63
Study: 3546125

Group type: EXPERIMENTAL
Intervention: Use of sterile gloves during suturing
Number of subjects: 242

Group type: COMPARATOR
Intervention: No gloves during suturing
Number of subjects: 242
Study: 29154132

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1-μg/kg over 10 min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5-μg/kg over 10 min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Zolpidem extended release
Number of subjects: 10
Study: 27581674

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 108
Study: 25369444

Group type: EXPERIMENTAL
Intervention: Atorvastatin reload
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 22614920

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 110 μg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 110 μg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20205100

Group type: EXPERIMENTAL
Intervention: cilazapril
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: bisoprolol
Number of subjects: 52

Group type: COMPARATOR
Intervention: amlodipine
Number of subjects: 52

Group type: COMPARATOR
Intervention: indapamide
Number of subjects: 52
Study: 18606020

Group type: EXPERIMENTAL
Intervention: Disease Management Model
Number of subjects: 500

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 500
Study: 15827692

Group type: EXPERIMENTAL
Intervention: gel
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: carmellose spray
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: oil
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mucin spray
Number of subjects: 120
Study: 11846848

Group type: EXPERIMENTAL
Intervention: Prototype brush head B
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Prototype brush head A
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sensiflex 2000 (control)
Number of subjects: 78
Study: 10636527

Group type: EXPERIMENTAL
Intervention: Low doses of diuretics (<80 mg/day of furosemide)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: High doses of diuretics (>=80 mg/day of furosemide)
Number of subjects: 111

Group type: COMPARATOR
Intervention: No treatment with diuretics prior to hospitalization
Number of subjects: 111
Study: 8577814

Group type: EXPERIMENTAL
Intervention: Triazolam 0.125 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 2200380

Group type: EXPERIMENTAL
Intervention: Self-management program (integrated workbook, one-to-one counseling, adherence-enhancing strategies)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (standard asthma pamphlets)
Number of subjects: 0
Study: 7302548

Group type: EXPERIMENTAL
Intervention: Immunoglobulin substitution
Number of subjects: 82

Group type: COMPARATOR
Intervention: No immunoglobulin substitution
Number of subjects: 82
Study: 29215533

Group type: EXPERIMENTAL
Intervention: Removal of epiretinal membrane without removal of internal limiting membrane (ILM)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Removal of epiretinal membrane with removal of internal limiting membrane (ILM)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 28203729

Group type: EXPERIMENTAL
Intervention: Liberal group (LG) - early postoperative oral fluid intake with apple juice (10 ml kg−1) offered if FLACC score ≥4 in PACU
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group (CG) - treated according to institutional opioid protocol, drinking allowed only upon return to the ward
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Liberal group (LG)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 231
Study: 26439052

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil (Group PR, n= 44)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Propofol-ketamine (Group PK, n= 37)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil (Group PR)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Propofol-ketamine (Group PK)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 81
Study: 23363689

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Waiting-List (WL)
Number of subjects: 22
Study: 22193485

Group type: EXPERIMENTAL
Intervention: Apex locator (AL)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Periapical radiograph (PA)
Number of subjects: 46
Study: 19811503

Group type: EXPERIMENTAL
Intervention: frovatriptan 2.5 mg b.i.d.
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: frovatriptan 2.5 mg q.d.
Number of subjects: 410

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 410
Study: 17074147

Group type: EXPERIMENTAL
Intervention: 20 mg/d fluoxetine
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: One tablet of almitrine l/d and 20 mg oryzanol 3/d
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group (no antidepressant treatment)
Number of subjects: 241
Study: 15447755

Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Propranolol 40 mg plus Isosorbide-5-mononitrate 20 mg
Number of subjects: 22
Study: 11588526

Group type: EXPERIMENTAL
Intervention: Pravastatin, 40 mg/day for 6 months
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Pravastatin (subgroup of 15 subjects with low adenosine flow)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (subgroup of 15 subjects with low adenosine flow)
Number of subjects: 51
Study: 9842024

Group type: EXPERIMENTAL
Intervention: Pemirolast potassium (20 mg/d from 1 week before PTCA until follow-up angiography at 4 months)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control (no pemirolast)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Pemirolast potassium
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control
Number of subjects: 205
Study: 7813732

Group type: EXPERIMENTAL
Intervention: Reoperation for control of postoperative haemorrhage
Number of subjects: 654

Group type: COMPARATOR
Intervention: Control group (matched for sex and primary operation)
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Patients requiring reoperation
Number of subjects: 654
Study: 2572372

Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 1101943

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Automatic Cardiff Infusion apparatus for PGE2
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-automatic techniques for PGE2 and oxytocin infusion
Number of subjects: 100
Study: 31858865

Group type: EXPERIMENTAL
Intervention: Early Mobilization (EM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Early Rehabilitation (SER)
Number of subjects: 60
Study: 31299479

Group type: EXPERIMENTAL
Intervention: Cogmed Working‐Memory Training (CWMT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No-intervention
Number of subjects: 34
Study: 28537443

Group type: EXPERIMENTAL
Intervention: Serum PAPP-A
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Serum proMBP
Number of subjects: 683
Study: 25262139

Group type: EXPERIMENTAL
Intervention: Uncertainty salience and God concept priming
Number of subjects: 120

Group type: COMPARATOR
Intervention: Uncertainty salience and neutral prime
Number of subjects: 120

Group type: COMPARATOR
Intervention: Insecurity salience and God concept priming
Number of subjects: 120

Group type: COMPARATOR
Intervention: Insecurity salience and neutral prime
Number of subjects: 120
Study: 23234618

Group type: EXPERIMENTAL
Intervention: Solifenacin plus tamsulosin
Number of subjects: 398

Group type: COMPARATOR
Intervention: Placebo plus tamsulosin
Number of subjects: 398
Study: 21752077

Group type: EXPERIMENTAL
Intervention: Paper case
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Standardised patient (SP) presentation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: DVD presentation
Number of subjects: 3
Study: 18650223

Group type: COMPARATOR
Intervention: Light-exposed TPN (LE)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Light-protected TPN (LP)
Number of subjects: 59
Study: 16942429

Group type: EXPERIMENTAL
Intervention: Er:YAG laser preparation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional mechanical preparation
Number of subjects: 40
Study: 15236813

Group type: EXPERIMENTAL
Intervention: Experiential learning intervention focusing on risks of smoking
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Experiential learning intervention focusing on feasibility of quitting
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 144
Study: 11372041

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 111
Study: 9227688

Group type: EXPERIMENTAL
Intervention: Spatiomotor cueing during motor activity
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 50
Study: 7968427

Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Celiprolol and Atenolol
Number of subjects: 11
Study: 3034795

Group type: EXPERIMENTAL
Intervention: Irradiation of retroperitoneal lymph nodes after orchidectomy
Number of subjects: 152

Group type: COMPARATOR
Intervention: Surveillance only after orchidectomy
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Both groups (irradiation and surveillance)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Irradiation
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Chemotherapy for relapsed patients
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Absence of embryonal carcinoma and presence of teratocarcinoma
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Increased serum concentrations of tumour markers before orchidectomy
Number of subjects: 152
Study: 31344303

Group type: EXPERIMENTAL
Intervention: Surgeons seen first in their work shift
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgeons seen toward the end of their work shift
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Each additional patient appointment in the doctors' work shift
Number of subjects: 0
Study: 28158579

Group type: EXPERIMENTAL
Intervention: Bevacizumab-paclitaxel (10 mg/kg bevacizumab on Days 1 and 15, paclitaxel 90 mg/m2 on Days 1, 8, and 15, repeated every 4 weeks)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo-paclitaxel (placebo on Days 1 and 15, paclitaxel 90 mg/m2 on Days 1, 8, and 15, repeated every 4 weeks)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bevacizumab-paclitaxel
Number of subjects: 54
Study: 25554360

Group type: EXPERIMENTAL
Intervention: Beetroot juice (0.45g nitrate; 5mM) for three days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lactated Ringer's (control)
Number of subjects: 6
Study: 23263998

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (eccentric exercises)
Number of subjects: 64
Study: 21164065

Group type: EXPERIMENTAL
Intervention: 800 mg i.v. ibuprofen (infused over five to seven minutes)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: i.v. ibuprofen
Number of subjects: 12
Study: 18640378

Group type: EXPERIMENTAL
Intervention: Combination of BBR (90 mg/[kg d], oral) with SIMVA (6 mg/[kg d], oral)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Combination of BBR with SIMVA
Number of subjects: 63

Group type: COMPARATOR
Intervention: SIMVA (6 mg/[kg d], oral)
Number of subjects: 63
Study: 16522699

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE; 0.625 mg) with 2.5 mg medroxyprogesterone acetate (MPA)
Number of subjects: 1416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1416
Study: 12667032

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics, angiotensin II receptor blockers, ACE inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers and calcium-channel blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10814774

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Subjective depressive symptoms
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 36
Study: 9101936

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (n = 35)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Open surgery (n = 27)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Peritoneal carcinomatosis (PC) (n = 5)
Number of subjects: 67
Study: 1654240

Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant human alpha-interferon (alpha-2a) thrice weekly for eight weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 6137646

Group type: EXPERIMENTAL
Intervention: Live oral attenuated bovine rotavirus vaccine strain RIT 4237
Number of subjects: 36
Study: 26792391

Group type: EXPERIMENTAL
Intervention: PREFER strategy (person-centred integrated Palliative advanced homecaRE and heart FailurE caRe)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 29924029

Group type: EXPERIMENTAL
Intervention: Real VR group (n=12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham VR group (n=11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (n=11)
Number of subjects: 23
Study: 26802980

Group type: EXPERIMENTAL
Intervention: Information on a continuum from mental health to mental illness
Number of subjects: 1679

Group type: COMPARATOR
Intervention: Information on a strict dichotomy of mental health and mental illness
Number of subjects: 1679

Group type: COMPARATOR
Intervention: No information (control group)
Number of subjects: 1679
Study: 24593170

Group type: EXPERIMENTAL
Intervention: CZP 200 mg every other week plus methotrexate
Number of subjects: 204

Group type: COMPARATOR
Intervention: CZP 400 mg every 4 weeks plus methotrexate
Number of subjects: 204
Study: 22884107

Group type: EXPERIMENTAL
Intervention: Carotid intima-media thickness (cIMT) measured using B-mode ultrasound at EDIC year 12
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure adjustment
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Shorter duration of DM
Number of subjects: 889
Study: 20807469

Group type: EXPERIMENTAL
Intervention: Active Management plus Cognitive Behavioural Approach (AM+CBA)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Active Management (AM)
Number of subjects: 701
Study: 17593406

Group type: EXPERIMENTAL
Intervention: Whitestrips (WS) - 6% hydrogen peroxide gel, applied twice a day for 30 min
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Vivadent Vivastyle (VS) - 10% carbamide peroxide gel, worn for 60 min once a day
Number of subjects: 47

Group type: COMPARATOR
Intervention: Both WS and VS
Number of subjects: 47
Study: 11426357

Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural analgesia (TEA)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Paravertebral block (PVB)
Number of subjects: 41
Study: 9249106

Group type: EXPERIMENTAL
Intervention: Immediate 8% sevoflurane in 70% nitrous oxide (HS)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Incremental sevoflurane in 70% nitrous oxide (GS)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Incremental halothane in 70% nitrous oxide (HAL)
Number of subjects: 46
Study: 8297448

Group type: EXPERIMENTAL
Intervention: Potassium chloride (Group I)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Potassium magnesium aspartate (Inzolen, Group II)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 207
Study: 3105906

Group type: EXPERIMENTAL
Intervention: Buserelin (d‐Ser‐[TBU]6 LHRH ethylamide) prescribed in two different dosage schedules to twenty men and in a single dosage schedule to eight women
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (ten male controls and nine female controls)
Number of subjects: 48
Study: 30287704

Group type: EXPERIMENTAL
Intervention: Audiovisual Distraction (AVD)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Combination of Tell Show Do (TSD) and Audiovisual Distraction (AVD)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Tell Show Do (TSD)
Number of subjects: 400
Study: 28159816

Group type: EXPERIMENTAL
Intervention: Research-grade systolic BP measurement
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Routine, research-grade, and daytime ambulatory systolic BP
Number of subjects: 275
Study: 26219696

Group type: EXPERIMENTAL
Intervention: Ultrasound corticomedullary strain
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Doppler end‐diastolic velocity (EDV)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Doppler peak systolic velocity (PSV)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Doppler resistive index (RI)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Duration of transplantation
Number of subjects: 45
Study: 24152375

Group type: EXPERIMENTAL
Intervention: 100,000 IU Vitamin D₂ (ergocalciferol)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: 100,000 IU Vitamin D₃ (cholecalciferol)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 342
Study: 21918593

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg/day)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pravastatin (80 mg/day)
Number of subjects: 6
Study: 19180720

Group type: EXPERIMENTAL
Intervention: PEDI assessment
Number of subjects: 174
Study: 17006995

Group type: EXPERIMENTAL
Intervention: Senna tablet (180 mg)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Sodium phosphate solution (95 mL)
Number of subjects: 134
Study: 14586240

Group type: EXPERIMENTAL
Intervention: Early closure of stoma (mean delay of 10.0 +/- 0.8 days after initial procedure)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Late closure of stoma (mean delay of 11.4 +/- 3.7 weeks)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Early closure of stoma
Number of subjects: 39

Group type: COMPARATOR
Intervention: Late closure of stoma
Number of subjects: 39
Study: 10781196

Group type: EXPERIMENTAL
Intervention: Subcutaneous Havrix(R) vaccine, 720 EL.U. at time 0 and 6 months
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Subcutaneous Havrix(R) vaccine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intramuscular Havrix(R) vaccine, 720 EL.U. at time 0 and 6 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intramuscular Havrix(R) vaccine
Number of subjects: 45
Study: 8973771

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (Co.Q10)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 1591977

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg/70 kg) after morphine (4 mg/70 kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg/70 kg) after morphine (8 mg/70 kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg/70 kg) after morphine (16 mg/70 kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Digit Symbol Substitution Test performance
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo pretreatment
Number of subjects: 5